Chicago, IL, United States of America

Kym Brünggel

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Anokion Sa, The University of Chicago. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kym Brünggel. Retrieved from https://idiyas.com/inventor/kym-brünggel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kym Brünggel: Innovator in Immune Tolerance

Introduction

Kym Brünggel is a notable inventor based in Chicago, IL (US). He has made significant contributions to the field of immunology, particularly in developing methods to promote immune tolerance. His innovative work has the potential to impact the way protein-based drugs are administered, reducing unwanted immune responses.

Latest Patents

Kym Brünggel holds a patent titled "Compositions and methods concerning immune tolerance." This patent provides compositions that comprise mannose-fused antigens designed to target mannose receptors. The compositions may be utilized to prevent immunity or diminish an immune response to protein-based drugs that would otherwise elicit such responses. He has 1 patent to his name.

Career Highlights

Throughout his career, Kym has worked with prestigious institutions, including the University of Chicago and Anokion SA. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Kym Brünggel has collaborated with notable colleagues such as Jeffrey A. Hubbell and David Scott Wilson. These partnerships have further enhanced his research and innovation in immune tolerance.

Conclusion

Kym Brünggel is a distinguished inventor whose work in immune tolerance is paving the way for advancements in immunology. His contributions are essential for the future of protein-based drug therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…